Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) FCF Margin (2016 - 2025)

Historic FCF Margin for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 152.09%.

  • Jaguar Health's FCF Margin rose 519300.0% to 152.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 220.82%, marking a year-over-year increase of 559800.0%. This contributed to the annual value of 251.52% for FY2024, which is 890400.0% up from last year.
  • Per Jaguar Health's latest filing, its FCF Margin stood at 152.09% for Q3 2025, which was up 519300.0% from 207.89% recorded in Q2 2025.
  • Jaguar Health's FCF Margin's 5-year high stood at 152.09% during Q3 2025, with a 5-year trough of 2573.25% in Q2 2021.
  • Its 5-year average for FCF Margin is 486.83%, with a median of 300.26% in 2024.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -24468800bps in 2021, then soared by 22152500bps in 2022.
  • Over the past 5 years, Jaguar Health's FCF Margin (Quarter) stood at 428.99% in 2021, then surged by 54bps to 197.02% in 2022, then crashed by -64bps to 323.96% in 2023, then skyrocketed by 31bps to 223.03% in 2024, then surged by 32bps to 152.09% in 2025.
  • Its FCF Margin stands at 152.09% for Q3 2025, versus 207.89% for Q2 2025 and 330.44% for Q1 2025.